Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Anesthesiology|September 1, 2023
Neurocognitive Effect of Biased µ-Opioid Receptor Agonist Oliceridine, a Utility Function Analysis and Comparison with MorphineLaurence Moss, Hemme Hijma, Mark Demitrack, et al.
Parkinsonism & Related Disorders|October 8, 2018
Predictors of simulated driving performance in Huntington's diseaseMilou Jacobs, Ellen P Hart, Yuri Mejia Miranda, et al.
Scientific Reports|November 27, 2019
Publisher Correction: Mitochondrial function is impaired in the skeletal muscle of pre-frail elderlyPénélope A Andreux, Marcus P J van Diemen, Maxime R Heezen, et al.
British Journal of Clinical Pharmacology|May 15, 2025
Sentinel dosing: A proposed algorithm to guide decision making on which cohorts in early phase clinical pharmacology trials should use this approachJules A A C Heuberger, Perry de Jongh, Ewoud-Jan van Hoogdalem, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 16, 2019
No synergistic effect of subtherapeutic doses of donepezil and EVP-6124 in healthy elderly subjects in a scopolamine challenge modelAnne Catrien Baakman, Ricardo Alvarez-Jimenez, Gordon Loewen, et al.
Scientific Reports|June 6, 2018
Mitochondrial function is impaired in the skeletal muscle of pre-frail elderlyPénélope A Andreux, Marcus P J van Diemen, Maxime R Heezen, et al.
Traffic Injury Prevention|October 2, 2018
Altered driving performance of symptomatic Huntington's disease gene carriers in simulated road conditionsMilou Jacobs, Ellen P Hart, Yuri Mejia Miranda, et al.
Clinical and Translational Science|October 25, 2022
Muscle velocity recovery cycles as pharmacodynamic biomarker: Effects of mexiletine in a randomized double-blind placebo-controlled cross-over studyTitia Q Ruijs, Ingrid W Koopmans, Marieke L de Kam, et al.
Clinical and Translational Science|May 7, 2024
Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patientsEva Thijssen, Bert Tuk, Michel Cakici, et al.
British Journal of Clinical Pharmacology|March 27, 2016
Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciaticaPieter Okkerse, Justin L Hay, Eve Versage, et al.
Pageof 12